This web presentation presents an overview of FDA's requirements for approval/marketing of a Biosimilar (Generic Biologic) product. The webinar covers the Biosimilar product testing requirements (clinical and nonclinical) and the Biosimilar approval pathway.
Biosimilar (Generic) Biologics In The USA: Approval Pathway - Webinar by GlobalCompliancePanel
11 March 2014, Fremont, United States
Introduction
Venue
Online Event
Online Event, 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA, Fremont, 94539, United States
Useful links
Organised by
GlobalCompliancePanel
Contact information
Related events
8th International Conference on Nanomaterials Science and Mechanical Engineering
7 July 2026 08:00 - 10 July 2026 18:00, Aveiro, Portugal
The 59th Annual International Meeting of the ESR Spectroscopy Group of the 91AV
13 April 2026 15:00 - 16 April 2026 23:00, Colchester, United Kingdom
6th International Conference on Emerging Advanced Nanomaterials
16 November 2026 08:00 - 20 November 2026 18:00, Newcastle, Australia
Chemical Biology meets Drug Discovery
14 September 2026 09:30 - 15 September 2026 16:30, Cambridge, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
